Product Description
Our reputable export firm offers Fludarabine Phosphate Injection to our foreign Clients since last many years from Surat, India.
- Generic Name : Fludarabine
- Brand Name : Fludara, Fludacel, Fludamax, Flobin, Fludabine, Racifluo
- Strength : 50mg
- Packing : Monocarton box along with patient leaflet
- Availability : In stock
- Dosage form : Injection
Highly Purified Oncological FormulationThis Fludarabine Phosphate Injection is meticulously manufactured for oncological use, ensuring high purity and strict adherence to safety and efficacy standards. Its formulation and packaging guarantee consistent performance in the clinical setting, providing reliable results for both chronic lymphocytic leukemia and non-Hodgkin's lymphoma patients.
Ready-to-Use Sterile Anticancer SolutionPackaged in glass vials and compatible with standard IV solutions, this product is designed for convenient hospital and clinical use. The injection is reconstituted using sterile water, resulting in a clear and colorless solution with a physiological pH, ensuring safe administration and optimal compatibility during intravenous infusion.
Reliable Regulatory Compliance and Storage InstructionsManufactured under stringent local regulatory requirements, this product meets quality and safety benchmarks for oncology medications. It possesses a 2-year shelf life and should be stored in a cool, dry environment, ensuring sustained efficacy and easy inventory management for healthcare providers and distributors.
FAQ's of Fludarabine Phosphate Injection:
Q: How should Fludarabine Phosphate Injection be reconstituted for administration?
A: To reconstitute Fludarabine Phosphate Injection, add exactly 2 mL of Sterile Water for Injection into the 50 mg glass vial. This process yields a clear, colorless solution containing 25 mg/mL of fludarabine phosphate, which should be administered intravenously.
Q: What indications is this injection used for in clinical practice?
A: Fludarabine Phosphate Injection is primarily prescribed for the treatment of hematologic cancers, specifically chronic lymphocytic leukemia and non-Hodgkin's lymphoma, as determined by a healthcare professional.
Q: When should this medication be administered to patients?
A: This injection is administered when a physician deems it medically necessary, typically as part of a chemotherapy protocol for indicated hematological malignancies. Dosing schedules depend on individual patient needs and treatment plans.
Q: Where should unused or waste material from Fludarabine Phosphate Injection be disposed?
A: Any unused product, reconstituted solution, or waste material must be disposed of according to local regulations for cytotoxic agents to ensure safety and environmental protection.
Q: What are the storage requirements for this injectable product?
A: Fludarabine Phosphate Injection should be stored in a cool, dry place away from direct sunlight. It maintains its stability and effectiveness for up to 2 years when stored under these conditions.
Q: How does the compatibility with standard IV solutions benefit healthcare providers?
A: Being compatible with standard IV solutions streamlines the preparation and administration process, enabling seamless integration into established hospital protocols and minimizing preparation errors.
Q: What precautions must be taken when handling this medication?
A: As a cytotoxic agent, Fludarabine Phosphate Injection should be handled with care. Appropriate protective equipment should be worn during reconstitution and administration to prevent accidental exposure.